Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-05-02
DOI
https://doi.org/10.1186/s13195-025-01745-3
Citations
3
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
4.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease

Brianna Askew, Carolyn Revta, Irfan Qureshi, Yuqi Qiu et al.
3 citations
Alzheimer s Research & Therapy
Dementia and Cognitive Impairment Research
4.41
article

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease

Brianna Askew, Carolyn Revta, Irfan Qureshi, Yuqi Qiu, Howard Feldman, Lia Donahue, Diane M. Jacobs, Stephen Kaplita, Sophie Stukas, Cheryl L. Wellington, Vladimir Coric, Karen Messer, David P. Salmon, Gabriel C. Léger, James Brewer
article en
3 citations

Abstract

No abstract available for this paper.
Alzheimer s Research & TherapyVol. 17(1)
University of British Columbia (CA), University of California San Diego (US), Biohaven Pharmaceuticals (United States) (US), Alzheimer’s Disease Neuroimaging Initiative (US), International Collaboration On Repair Discoveries (CA), East China Normal University (CN)
National Institutes of Health, University of California, San Diego, National Institute on Aging
Openalex Percentile: Top 6%
Dementia and Cognitive Impairment Research
4.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease — Brianna Askew, Carolyn Revta, et al. · Alzheimer s Research & Therapy (2025) | TGRS Research Map | TGRS